日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

AI662270/GRP94 axis couples the unfolded protein response to mitochondrial dynamics during acute myocardial infarction.

AI662270/GRP94 轴将未折叠蛋白反应与急性心肌梗死期间的线粒体动力学联系起来。

Ding Suling, Liu Wen, Zhang Zhiwei, Yang Xiyang, Sun Dili, Zhu Jianfu, Zhu Xiaowei, Wang Shijun, Xie Mengshi, Shi Hongyu, Ge Junbo, Yang Xiangdong

Covalent Organic Frameworks for Immunoassays: A Review

共价有机框架在免疫测定中的应用:综述

Yang, Suling; Liu, Hongmin

Prevalence and clinical significance of HBeAg-positive chronic hepatitis B patients with and without anti-HBe antibody

HBeAg阳性慢性乙型肝炎患者(伴或不伴抗-HBe抗体)的患病率和临床意义

Xue, Ruifei; Wang, Jian; Zhan, Jie; Zhang, Zhiyi; Jiang, Suling; Liu, Jiacheng; Wang, Li; Yan, Xiaomin; Yin, Shengxia; Tong, Xin; Ding, Weimao; Li, Jie; Chen, Yuxin; Huang, Rui; Wu, Chao

Microenvironment-induced CREPT expression by cancer-derived small extracellular vesicles primes field cancerization

微环境诱导的癌症衍生小细胞外囊泡 CREPT 表达引发癌变

Yuting Lin, Hanguo Jiang, Jun Li, Fangli Ren, Yinyin Wang, Ying Qiu, Jianghua Li, Mengdi Li, Ying Wang, Liu Yang, Yunhao Song, Huihui Jia, Wanli Zhai, Yanshen Kuang, Hanyang Yu, Wenyuan Zhu, Suling Liu, Eiichi Morii, Christian Ensinger, Charles David, Hanqiu Zheng, Jianguo Ji, Hongxia Wang, Zhijie C

Dysregulated Ribosome Biogenesis Is a Targetable Vulnerability in Triple-Negative Breast Cancer: MRPS27 as a Key Mediator of the Stemness-inhibitory Effect of Lovastatin

核糖体生物合成失调是三阴性乳腺癌中可靶向的弱点:MRPS27 是洛伐他汀抑制干细胞特性的关键介质

Chanjuan Zheng, Hui Yao, Lu Lu, Hongqi Li, Lei Zhou, Xueyan He, Xi Xu, Hongzhuo Xia, Siyu Ding, Yiyuan Yang, Xinyu Wang, Muyao Wu, Lian Xue, Sisi Chen, Xiaojun Peng, Zhongyi Cheng, Yian Wang, Guangchun He, Shujun Fu, Evan T Keller, Suling Liu, Yi-Zhou Jiang, Xiyun Deng

Vertical pathway inhibition of receptor tyrosine kinases and BAD with synergistic efficacy in triple negative breast cancer

受体酪氨酸激酶和 BAD 的垂直通路抑制对三阴性乳腺癌具有协同作用

Yan Qin Tan #, Yi-Shiou Chiou #, Hui Guo, Shuwei Zhang, Xiaoming Huang, Dukanya Dukanya, Arun M Kumar, Shreeja Basappa, Suling Liu, Tao Zhu, Basappa Basappa, Vijay Pandey, Peter E Lobie5

SOSTDC1 Nuclear Translocation Facilitates BTIC Maintenance and CHD1-Mediated HR Repair to Promote Tumor Progression and Olaparib Resistance in TNBC

SOSTDC1 核转位促进 BTIC 维持和 CHD1 介导的 HR 修复,从而促进 TNBC 中的肿瘤进展和奥拉帕尼耐药性

Qiaodan Deng, Jiankun Qiang, Cuicui Liu, Jiajun Ding, Juchuanli Tu, Xueyan He, Jie Xia, Xilei Peng, Siqin Li, Xian Chen, Wei Ma, Lu Zhang, Yi-Zhou Jiang, Zhi-Ming Shao, Ceshi Chen, Suling Liu, Jiahui Xu, Lixing Zhang

PMN-MDSCs modulated by CCL20 from cancer cells promoted breast cancer cell stemness through CXCL2-CXCR2 pathway

癌细胞 CCL20 调控的 PMN-MDSC 通过 CXCL2-CXCR2 通路促进乳腺癌细胞干性

Rui Zhang #, Mengxue Dong #, Juchuanli Tu, Fengkai Li, Qiaodan Deng, Jiahui Xu, Xueyan He, Jiajun Ding, Jie Xia, Dandan Sheng, Zhaoxia Chang, Wei Ma, Haonan Dong, Yi Zhang, Lixing Zhang, Lu Zhang, Suling Liu

Discovery of a first-in-class ANXA3 degrader for the treatment of triple-negative breast cancer

发现用于治疗三阴性乳腺癌的首创 ANXA3 降解剂

Yongxi Liang, Delin Min, Hulin Fan, Kunlin Liu, Juchuanli Tu, Xueyan He, Bingjie Liu, Lu Zhou, Suling Liu, Xun Sun

Regulation of ERα-dependent breast cancer metastasis by a miR-29a signaling

miR-29a 信号对 ERα 依赖性乳腺癌转移的调控

Jinhui Lü #, Qian Zhao #, Yuefan Guo, Danni Li, Heying Xie, Cuicui Liu, Xin Hu, Suling Liu, Zhaoyuan Hou, Xunbin Wei, Deyou Zheng, Richard G Pestell, Zuoren Yu